Sessioni Comunicazioni Orali
Pharmacoepidemiology - Session I
Mercoledì 28 Ottobre 2015 / 11.00-13.00
358 | Breathomics distinguishesbetween anti-IgE-treated and non-treated adults with severe asthma Santini G., Di Carlo S., Benso A., Mores N., Brinkman P., Valente S., Montuschi P., Macagno F., Sterk PJ., Montuschi P. |
383 | Lights And Shadows In The Anti-Diabetic Therapy Pirolo R., Bettiol A., Bolcato J., Deambrosis P., Franchin G., Paccagnella A., Giusti P., Chinellato A. |
435 | Gabapentin and pregabalin use in general practice: evaluation of use and appropriateness during the years 2005—2011 Italiano D., Ferrara R., Cannata A., Alibrandi A., Giorgianni F., Trifirò G., Tari M., Spina E., Arcoraci V. |
619 | Exposure to potentially teratogenic drugs in pregnancy and perinatal outcomes: observational study on deliveries occurred in Emilia Romagna region between 2009 and 2011 Piccinni C., Fabbri S., Naldi I., Mostacci B., Bisulli F., Tinuper P., D'Alessandro R., Poluzzi E. |
571 | Can a clinical educational program improve the management of chronic obstructive pulmonary disease (COPD)? Results from a prospective cohort study in the Sicilian general practice setting Ferrara R., Ientile V., Mocciaro E., Alecci U., Scoglio R., Arcoraci V., Vancheri C., Vitulo P., Caputi AP., Trifirò G. |
671 | Identifying cases of type 2 diabetes from heterogeneous data sources: strategy from the EMIF Project Roberto G., Leal I., Sattar N., Loomis K., Avillach P., Egger P., van Wijngaarden R., Ansell D., Reisberg S., Tammesoo M., Alavere H., Pasqua A., Pedersen L., Cunningham J., Tramontan L., Mayer MA., Herings R., Coloma P., Lapi F., Sturkenboom MCJM., van der Lei J., Schuemie M., Rijnbeek P., Gini R. |
682 | Experience with generic medicines in Italy: a questionnaire–based survey of prescribers, pharmacists and patients Poluzzi E., Piccinni C., Fontolan F., Zucconi S., De Ponti F. |
692 | Quality of life and drug use: a gender analysis Tarozzi A., Quercioli F., Hrelia P., Bernini C. |